Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

Bioidentical hormones are structurally identical to the hormones naturally produced by the human body. Learn how bioidentical hormone therapy works, how it differs from synthetic hormones, and how physicians evaluate hormone health in longevity medicine.

Cognitive health can begin changing years before symptoms appear. Learn how early brain testing, cognitive baseline assessments, and preventive strategies help monitor memory, attention, and brain performance as part of longevity medicine.

Bioidentical hormones are often discussed as if they are a simple solution for aging, energy, menopause, or vitality. In reality, hormone health is more nuanced. In preventive longevity medicine, hormone therapy is evaluated within the broader context of sleep, metabolic health, body composition, cardiovascular risk, recovery, and long-term healthspan.

Insulin resistance often develops silently years before diabetes is diagnosed. Several blood tests can help detect early metabolic dysfunction, including fasting insulin, HOMA-IR, triglyceride-to-HDL ratio, and glucose markers. Understanding these tests can help identify metabolic risk earlier and support preventive longevity medicine strategies.

HOMA-IR is a calculated laboratory marker used to estimate insulin resistance using fasting glucose and fasting insulin levels. Because insulin resistance can develop years before diabetes appears, HOMA-IR helps identify early metabolic dysfunction and cardiometabolic risk within a preventive longevity medicine framework.

Fasting insulin and hemoglobin A1C measure different aspects of metabolic health. While A1C reflects average blood glucose over time, fasting insulin can reveal insulin resistance years before blood sugar rises. Understanding the difference helps detect metabolic dysfunction earlier within a longevity medicine framework.

Visceral fat is the metabolically active fat stored around internal organs and is strongly associated with insulin resistance, inflammation, and cardiometabolic disease. Understanding how visceral fat influences metabolic health is a key component of preventive longevity medicine and early disease detection.

Metabolic syndrome is a cluster of metabolic risk factors—including abdominal fat, insulin resistance, elevated blood pressure, and abnormal cholesterol—that significantly increase the risk of cardiovascular disease and type 2 diabetes. Understanding metabolic syndrome helps identify cardiometabolic risk earlier within a preventive longevity medicine framework.

Continuous glucose monitoring (CGM) allows real-time insight into blood sugar patterns, helping detect early insulin resistance, metabolic dysfunction, and glucose variability. In longevity medicine, CGM provides personalized metabolic data that can guide nutrition, lifestyle changes, and preventive strategies to improve metabolic health and long-term healthspan.

Skeletal muscle plays a central role in metabolic health, insulin sensitivity, and long-term disease prevention. In longevity medicine, maintaining healthy muscle mass supports glucose regulation, metabolic flexibility, strength, and healthy aging while reducing the risk of insulin resistance, frailty, and cardiometabolic disease.

Metabolic health is one of the most important drivers of long-term healthspan. Insulin resistance, visceral fat, and poor body composition can increase the risk of cardiovascular disease, weight gain, and metabolic dysfunction long before diabetes develops. This longevity medicine guide explains how early detection, testing, and physician-guided care help protect metabolic health.

Resistance training plays an important role in maintaining muscle mass, metabolic health, and physical resilience with aging. Because skeletal muscle influences metabolism, mobility, and strength, regular strength training is increasingly recognized as an important factor supporting healthy aging and longevity.